Markets:

Overview

News

Currencies

International

Treasuries

Salarius Pharmaceuticals, Inc. - Common Stock (NQ:SLRX)

0.6648 +0.0160 (+2.47%)

Streaming Delayed Price Updated: 1:13 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Salarius Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 27, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 27, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 22, 2022

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 22, 2022

Gainers Vallon Pharmaceuticals (NASDAQ:VLON) shares moved upwards by 94.7% to $2.2 during Friday's pre-market session. The company's market cap stands at $14.9 million.

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

55 Biggest Movers From Friday ↗

April 25, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 16, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 15, 2022

Gainers

Via Benzinga

95 Biggest Movers From Friday ↗

March 14, 2022

Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9....

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 11, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. Clearside Biomedical's stock is trading at a volume...

Via Benzinga

50 Stocks Moving In Friday's Mid-Day Session ↗

March 11, 2022

Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 11, 2022

Good morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

30 Stocks Moving in Friday's Pre-Market Session ↗

March 11, 2022

Gainers Excellon Resources Inc. (NYSE: EXN) rose 133.7% to $2.29 in pre-market trading after jumping around 13% on Thursday. Marygold Companies (NYSE: MGLD) rose 107.4% to...

Via Benzinga

78 Biggest Movers From Yesterday ↗

March 11, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (...

Via Benzinga

Salarius Pharmaceuticals: Q4 Earnings Insights ↗

March 10, 2022

Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 10, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The company's market cap stands at $92.4 million. As per the press release, Q4...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 10, 2022

Gainers Salarius Pharmaceuticals (NASDAQ:SLRX) stock moved upwards by 31.4% to $0.49 during Thursday's regular session. The current volume of 2.4 million shares is 738...

Via Benzinga

Insiders Buying These 4 Penny Stocks ↗

March 10, 2022

US stock futures traded lower this morning after the Dow Jones gained more than 650 points on Wednesday. Investors, meanwhile, focused on some notable insider trades

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 09, 2022

Gainers

Via Benzinga

Salarius Pharmaceuticals's Earnings: A Preview ↗

March 09, 2022

Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement....

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 14, 2022

Gainers Molecular Partners (NASDAQ:MOLN) shares moved upwards by 11.9% to $31.66 during Friday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 14, 2022

Happy Friday, trader! We're starting off the day right with an overview of the biggest pre-market stock movers for today!

Via InvestorPlace

Salarius Plans To Enter $15B Protein Degradation Space With DeuteRx Deal ↗

January 13, 2022

Salarius Pharmaceuticals Inc (NASDAQ: SLRX) has agreed to acquire an oral, small molecule targeted protein degradation portfolio against cancer from DeuteRx...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 13, 2022

Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...

Via Benzinga

The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact ↗

January 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio...

Via Benzinga

Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday ↗

December 14, 2021

Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 18, 2021

Gainers NeuroOne Medical Tech (NASDAQ:NMTC...

Via Benzinga

Could the Future Hold a Less Toxic Cancer Treatment in the Form of a Tablet? ↗

October 18, 2021

Image by PublicDomainPictures from Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...

Via Benzinga

Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients ↗

September 29, 2021

Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.